Article
Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
The Journal of clinical investigation - 1 Feb 1993
Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P
Abstract excerpt
Patients with terminal renal insufficiency suffer from an increased incidence of atherosclerotic diseases. Elevated plasma concentrations of lipoprotein(a) [Lp(a)] have been established as a genetically controlled risk factor for these diseases. Variable alleles at the apo(a) gene locus determine...
Topics
- Adult
- Aged
- Apolipoproteins
- Apolipoproteins B
- Apoprotein(a)
- Arteriosclerosis
- Cholesterol
- Female
- Humans
- Kidney Failure, Chronic
- Lipoprotein(a)
- Male
